Skip to main content
. 2017 Mar 8;2017:3671751. doi: 10.1155/2017/3671751

Figure 7.

Figure 7

Sketch map of possible mechanisms under which MG132 attenuates DN. MG132 inhibits proteasome activity, leading to the upregulation of Nrf2 and IκB. For one thing, antioxidant genes, such as NQO-1, are activated due to the upregulation of Nrf2; therefore, renal oxidative damage is reduced. On the other hand, NF-κB is downregulated secondary to the upregulation of IκB, resulting in the reduction of inflammation. Consequently, MG132 alleviates diabetic nephropathy.